Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Blood Advances|January 10, 2019
Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemiaJoseph Wynne, David Wright, Wendy Stock
Current Hematologic Malignancy Reports|September 13, 2020
New Approaches to Treating Challenging Subtypes of ALL in AYA PatientsKevin Prescott, Michael Jacobs, Wendy Stock, et al.
Leukemia & Lymphoma|November 5, 2019
Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemiaBenjamin A Derman, Mitchell Streck, Joseph Wynne, et al.
Blood|September 2, 2015
Rap1 and its effector RIAM are required for lymphocyte traffickingWenjuan Su, Joseph Wynne, Elaine M Pinheiro, et al.
Blood Cancer Journal|March 4, 2021
OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemiaBartholomew J Eisfelder, Caner Saygin, Joseph Wynne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2025
FDA Approval Summary: Abatacept for the Prophylaxis of Acute GVHDKelly J Norsworthy, Donna R Rivera, Joseph Wynne, et al.
JCO Oncology Practice|April 30, 2026
Real-World Treatment Patterns and Outcomes Among Patients With Newly Diagnosed AML in the United StatesElizabeth Dianne Pulte, Laura L Fernandes, Kelly Norsworthy, et al.
American Journal of Hematology|December 13, 2025
Real-World Outcomes and Treatment Patterns in Patients With Acute Myeloid Leukemia and TP53 Gene Mutation or 17p DeletionRebecca Bystrom, Laura L Fernandes, Joseph Wynne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2022
Project Confirm: Accelerated Drug Approvals for Chronic Myeloid LeukemiaKendra L Sweet, Jorge E Cortes, Jane F Apperley, et al.
Pageof 1